These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10693068)

  • 21. Impacts of the Finnish service screening programme on breast cancer rates.
    Anttila A; Sarkeala T; Hakulinen T; Heinävaara S
    BMC Public Health; 2008 Jan; 8():38. PubMed ID: 18226204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 1996; 3(4):200-3. PubMed ID: 9041485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressiveness of screen-detected breast cancers.
    Hakama M; Holli K; Isola J; Kallioniemi OP; Kärkkäinen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J
    Lancet; 1995 Jan; 345(8944):221-4. PubMed ID: 7741862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of invasive breast cancers detected by screening mammography.
    Zahl PH; Maehlen J; Welch HG
    Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The state of the organised mammography screening in Hungary in 2006].
    Kovács A; Döbrossy L; Budai A; Boncz I; Cornides A
    Orv Hetil; 2007 May; 148(19):879-85. PubMed ID: 17478403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
    Boer R; de Koning H; Threlfall A; Warmerdam P; Street A; Friedman E; Woodman C
    BMJ; 1998 Aug; 317(7155):376-9. PubMed ID: 9694752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
    J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region.
    Wu JC; Anttila A; Yen AM; Hakama M; Saarenmaa I; Sarkeala T; Malila N; Auvinen A; Chiu SY; Chen TH
    Breast Cancer Res Treat; 2010 Jun; 121(3):671-8. PubMed ID: 19890708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of modelling mammography screening strategies.
    Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
    Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A community peer-volunteer telephone reminder call to increase breast cancer-screening attendance.
    Goelen G; De Clercq G; Hanssens S
    Oncol Nurs Forum; 2010 Jul; 37(4):E312-7. PubMed ID: 20591795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.